GNNSF Stock Price, Chart, Stats & News

Genscript Biotech Corporation
Save
Genscript Biotech Corporation (GNNSF) does not currently pay a dividend.
7.01B
Market cap
–
Current P/E
94.34x
Forward P/E
GNNSF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Genscript Biotech Corporation, an investment holding firm, operates on a global scale as a leading provider of life science research products and services, serving North America, Europe, China, Japan, other Asia Pacific regions, and beyond. The company is structured into four distinct business units. Its Life Science Services and Products division delivers essential research support, encompassing gene synthesis, molecular cloning, oligonucleotide and peptide synthesis, protein engineering, antibody development, and the creation of molecular diagnostic tools and genome editing materials.
Similar securities
Based on sector and market capitalization
Report issue





